Citations

Clear

9383 citation(s) found for "Thomas, PS".

Intrahepatic neutrophil accumulation and extracellular trap formation are associated with posthepatectomy liver failure
Brunnthaler, Laura, Brenner, M, Herrmann, Lukas , Schrottmaier, Waltraud C. , Pirabe, Anita , Schmuckenschlager, Anna , Kern, A.E. , Huber, Felix Xaver, Michels, Lisa Emilie, Salzmann, Manuel , Hohensinner, Philipp J. , Kain, Renate , Pereyra, David , Brenner, Miriam, Santol, Jonas , Herrmann, Lukas, Kim, Sarang , Brostjan, Christine , Gruenberger, Thomas , Starlinger, Patrick , Assinger, Alice

Mayo Clinic

Hepatology Communications | December 15, 2023 | Volume: 8 | Issue: 1 | Pages: No page available

10.1097/hc9.0000000000000348 | PMID 38099865 Get It

Background: Posthepatectomy liver failure (PHLF) represents a life-threatening complication with limited therapeutic options. Neutrophils play a critical and dynamic role during regeneratory processes, but their role in human liver regeneration is incompletely understood, especially as underlying liver disease, detectable in the majority of patients, critically affects hepatic regeneration. Here we explored intrahepatic neutrophil accumulation and neutrophil extracellular traps (NETs) in patients with PHLF and validated the functional relevance of NETs in a murine partial hepatectomy (PHx) model. Methods: We investigated the influx of neutrophils, macrophages, eosinophils, and mast cells and the presence of their respective extracellular traps in liver biopsies of 35 patients undergoing hepatectomy (10 patients with PHLF) before and after the initiation of liver regeneration by fluorescence microscopy. In addition, NET formation and neutrophil activation were confirmed by plasma analysis of 99 patients (24 patients with PHLF) before and up to 5 days after surgery. Furthermore, we inhibited NETs via DNase I in a murine PHx model of mice with metabolically induced liver disease. Results: We detected rapid intrahepatic neutrophil accumulation, elevated levels of myeloperoxidase release, and NET formation in regenerating human livers, with a significantly higher increase of infiltrating neutrophils and NETs in patients with PHLF. Circulating markers of neutrophil activation, including elastase, myeloperoxidase, and citrullinated histone H3, correlated with markers of liver injury. In a murine PHx model, we showed that the inhibition of NET accelerated hepatocyte proliferation and liver regeneration. Conclusions: Patients with PHLF showed accelerated intrahepatic neutrophil infiltration and NET formation, which were associated with liver damage. Further, we identified postsurgical myeloperoxidase levels as predictive markers for adverse outcomes and observed that blocking NETs in a murine PHx model accelerated tissue regeneration.
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma
Sajisevi, Mirabelle , Nguyen, Kenny , Holcomb, Andrew J. , Vural, Emre , Davis, Kyle P. , Plonowska‐Hirschfeld, Karolina A. , Stein, John S. , Eskander, Antoine , Enepekides, Danny , Hier, Michael P. , Ryan, William R. , Section, American Head and Neck Society Salivary Gland, Aulet, Ricardo , Bell, Rebecca K. , Blasco, Michael A., Bowmaster, Vanessa B., Burruss, Clayton P. , Chung, Jeffson , Coffey, Charles S. , Cordero, Joehassin , Donovan, John, Du, Yue , Feinberg, Philip A. , Garvey, Emily A. , Goldstein, David P. , Goulart, Rafael Nunes, Grasl, Stefan , Giurintano, Jonathan P. , Hara, Jared H. , Hinni, Michael L., Hua, Nadia , Johnson‐Obaseki, Stephanie , Kalman, Noah S. , Khaja, Sobia F. , Ku, Jamie A., Lambert, Arnaud, Luu, Bao K. , Magliocca, Kelly R. , Santos, Luiz Roberto Medina dos , Michael, C. A., Miles, Brett A., Melo, Giulianno Molina de , Moore, Michael G. , Morand, Grégoire B. , Moura, Kauê, Mukdad, Laith , Noroozi, Hesameddin, Patel, Rusha , Paydarfar, Joseph A. , Savaria, Fabrice N., Shapiro, Justin , Stokes, William A. , Sulibhavi, Anita , Vendra, Varun , Vinh, Daniel , Virgen, Celina G. , Wooten, Christian , Woody, N.M. , Young, Geoffrey D., de Melo, Giulianno Molina , Morand, Gregoire B , CALLAS, PETER W. , Thomas, Carissa M. , Kakarala, Kiran , Section, American Head and Neck Society Salivary Gland, Asarkar, Ameya A , Chan, Kimberly , Chang, Brent A. , Cognetti, David M. , Cooper, Dylan Jacob , Donovan, John, Dundar, Yusuf , Dedivitis, Rogerio , Edwards, Heather , Erović, Boban M. , Goodman, Joseph , Goyal, Neerav , Gupta, Nikita , Habib, Andy , Hackman, Trevor , Henson, Christina , Juloori, Aditya , Kejner, Alexandra E , Michael, Cara, Sadeghi, Nader , Schmitt, Nicole C. , Shaver, Timothy B , Stoeckli, Sandro Johannes , John, Maie A. St. , Tasoulas, Jason

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | December 14, 2023 | Volume: 150 | Issue: 2 | Pages: 107

10.1001/jamaoto.2023.3952 | PMID 38095911 Get It

ImportancePostoperative radiation therapy for close surgical margins in low- to intermediate-grade salivary carcinomas lacks multi-institutional supportive evidence.ObjectiveTo evaluate the oncologic outcomes for low- and intermediate-grade salivary carcinomas with close and positive margins.Design, Setting, and ParticipantsThe American Head and Neck Society Salivary Gland Section conducted a retrospective cohort study from 2010 to 2019 at 41 centers. Margins were classified as R0 (negative), R1 (microscopically positive), or R2 (macroscopically positive). R0 margins were subclassified into clear (>1 mm) or close (≤1 mm). Data analysis was performed from June to October 2023.Main Outcomes and MeasuresMain outcomes were risk factors for local recurrence.ResultsA total of 865 patients (median [IQR] age at surgery, 56 [43-66] years; 553 female individuals [64%] and 312 male individuals [36%]) were included. Of these, 801 (93%) had parotid carcinoma and 64 (7%) had submandibular gland carcinoma, and 748 (86%) had low-grade tumors and 117 (14%) had intermediate-grade tumors, with the following surgical margins: R0 in 673 (78%), R1 in 168 (19%), and R2 in 24 (3%). Close margins were found in 395 of 499 patients with R0 margins (79%), for whom margin distances were measured. A total of 305 patients (35%) underwent postoperative radiation therapy. Of all 865 patients, 35 (4%) had local recurrence with a median (IQR) follow-up of 35.3 (13.9-59.1) months. In patients with close margins as the sole risk factor for recurrence, the local recurrence rates were similar between those who underwent postoperative radiation therapy (0 of 46) or observation (4 of 165 [2%]). Patients with clear margins (n = 104) had no recurrences. The local recurrence rate in patients with R1 or R2 margins was better in those irradiated (2 of 128 [2%]) compared to observed (13 of 64 [20%]) (hazard ratio [HR], 0.05; 95% CI, 0.01-0.24). Multivariable analysis for local recurrence found the following independent factors: age at diagnosis (HR for a 10-year increase in age, 1.33; 95% CI, 1.06-1.67), R1 vs R0 (HR, 5.21; 95% CI, 2.58-10.54), lymphovascular invasion (HR, 4.47; 95% CI, 1.43-13.99), and postoperative radiation therapy (HR, 0.10; 95% CI, 0.04-0.29). The 3-year local recurrence-free survivals for the study population were 96% vs 97% in the close margin group.Conclusions and RelevanceIn this cohort study of patients with low- and intermediate-grade major salivary gland carcinoma, postoperative radiation therapy for positive margins was associated with decreased risk of local recurrence. In isolation from other risk factors for local recurrence, select patients with close surgical margins (≤1 mm) may safely be considered for observation.
1224: THINK POSITIVE: IMPROVING INTERDISCIPLINARY INTRAVENOUS MEDICATION TITRATION MANAGEMENT
Thomas, Tracy A., Sederstrom, Jane, Munch, Paula, Petti, Jamie, Kiley, Brigid, Saint-Amour, Shae, Nyquist, Sharon, Thomas, Tracy, Davis, Kimberly, Black, Sarah

Mayo Clinic

Critical Care Medicine | December 14, 2023 | Volume: 52 | Issue: 1 | Pages: S584-S584

10.1097/01.ccm.0001003060.59455.b2 Get It

International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts
Timmins, Iain R. , Jones, Michael E. , O’Brien, Katie M. , Adami, Hans‐Olov , Aune, Dagfinn , Brantley, Kristen D. , Chen, Yu , DeHart, Jessica Clague , Clendenen, Tess V. , Fournier, A. , Hankinson, Susan E. , Houlston, Richard S. , Kirsh, Victoria A. , Linet, Martha S. , May, Anne M. , Rohan, Thomas E. , Ruddy, Kathryn J. , Sund, Malin , Vachon, Celine M. , Vatten, Lars J. , Visvanathan, Kala , Yuan, Jian‐Min , Zheng, Wei , Nichols, Hazel B. , Baglietto, Laura , Bertrand, Kimberly A , Brantley, Kristen D , Clague DeHart, Jessica , Clendenen, Tess V , Dossus, Laure , Eliassen, A Heather , Fletcher, Olivia , Fournier, Agnès , Håkansson, Niclas , Houlston, Richard S , Joshu, Corinne E , Kirsh, Victoria A , Kitahara, Cari M , Linet, Martha S , Park, Hannah Lui , Lynch, Brigid M , May, Anne M , Mellemkjær, Lene , Milne, Roger L , Palmer, Julie R , Ruddy, Kathryn J , Sánchez, Maria-Jose , Shu, Xiao-Ou , Steindorf, Karen , Sund, Malin , Vachon, Celine M. , Vatten, Lars J , Visvanathan, Kala , Weiderpass, Elisabete , Willett, Walter C , Wolk, Alicja , Zheng, Wei , Nichols, Hazel B , Sandler, Dale P , Jones, Michael E , O'Brien, Katie M , Aune, Dagfinn , Chen, Yu , Baglietto, Laura , Bertrand, Kimberly A. , Eliassen, A. Heather , Fletcher, Olivia , Håkansson, Niclas , Hankinson, Susan E. , Kitahara, Cari M. , Koh, Woon‐Puay , Milne, Roger L. , Palmer, Julie R. , Ricceri, Fulvio , Sánchez, María‐José , Shu, Xiao‐Ou , Smith-Byrne, Karl , Weiderpass, Elisabete , Willett, Walter C. , Wolk, Alicja , Sandler, Dale P. , Swerdlow, Anthony J. , Schoemaker, Minouk J.

Mayo Clinic

Journal of Clinical Oncology | December 11, 2023 | Volume: 42 | Issue: 8 | Pages: 927-939

10.1200/jco.23.01101 | PMID 38079601 Get It

PURPOSE There is strong evidence that leisure-time physical activity is protective against postmenopausal breast cancer risk but the association with premenopausal breast cancer is less clear. The purpose of this study was to examine the association of physical activity with the risk of developing premenopausal breast cancer. METHODS We pooled individual-level data on self-reported leisure-time physical activity across 19 cohort studies comprising 547,601 premenopausal women, with 10,231 incident cases of breast cancer. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% CIs for associations of leisure-time physical activity with breast cancer incidence. HRs for high versus low levels of activity were based on a comparison of risk at the 90th versus 10th percentiles of activity. We assessed the linearity of the relationship and examined subtype-specific associations and effect modification across strata of breast cancer risk factors, including adiposity. RESULTS Over a median 11.5 years of follow-up (IQR, 8.0-16.1 years), high versus low levels of leisure-time physical activity were associated with a 6% (HR, 0.94 [95% CI, 0.89 to 0.99]) and a 10% (HR, 0.90 [95% CI, 0.85 to 0.95]) reduction in breast cancer risk, before and after adjustment for BMI, respectively. Tests of nonlinearity suggested an approximately linear relationship ( Pnonlinearity = .94). The inverse association was particularly strong for human epidermal growth factor receptor 2–enriched breast cancer (HR, 0.57 [95% CI, 0.39 to 0.84]; Phet = .07). Associations did not vary significantly across strata of breast cancer risk factors, including subgroups of adiposity. CONCLUSION This large, pooled analysis of cohort studies adds to evidence that engagement in higher levels of leisure-time physical activity may lead to reduced premenopausal breast cancer risk.
“Winged” Eagle’s syndrome: neurophysiological findings in a rare cause of spinal accessory nerve palsy. Illustrative cases
Wu, Kitty Y. , Siddiqi, Fawaz , Yoo, John , Ohorodnyk, Pavlo, Ross, Douglas C. , Miller, Thomas A. , Mitchell, Eric C.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | December 11, 2023 | Volume: 6 | Issue: 24 | Pages: No page available

10.3171/case23358 | PMID 38079628 Get It

BACKGROUND Eagle’s syndrome (ES) classically describes dysphagia, globus sensation, and otalgia from an elongated and calcified styloid process or stylohyoid ligament. Compression of the spinal accessory nerve (SAN) has not been reported as an associated feature of ES or related variants. OBSERVATIONS The authors describe two cases of an atypical “winged” variant with SAN palsy resulting from compression by a posteriorly angulated or calcified styloid process. Both patients exhibited lateral scapular winging and atrophy of the trapezius and sternocleidomastoid muscles. Electrophysiological studies demonstrated motor unit preservation; therefore, surgical exploration, styloidectomy, and SAN decompression were performed through a transcervical approach. Postoperatively, both patients had improvements in pain and shoulder mobility, the return of muscle strength, and electrophysiological evidence of trapezius reinnervation. LESSONS Compression of the SAN, which can be identified both clinically and on electrodiagnostic testing, is an atypical finding that can result from a posteriorly angulated or calcified styloid process. This winged variant of ES should be included in the differential for SAN palsy, and a multidisciplinary approach is recommended for assessment and management.
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Kumar, Shaji , Adekola, Kehinde , Anderson, Larry D. , Costello, Caitlin, D’Angelo, Christopher R. , Elsedawy, Noura, Godby, Kelly, Hillengaß, Jens , Holmberg, Leona , Htut, Myo, Huff, Carol Ann , Hultcrantz, Malin , Larson, Sarah , Liedtke, Michaela , Omel, James, Robinson, Timothy, Sborov, Douglas W. , Valent, Jason , Varshavsky‐Yanovsky, Asya, Snedeker, Jenna, Holmberg, Leona , Anderson, Larry D , Callander, Natalie S. , Baljević, Muhamed , Baz, Rachid , Campagnaro, Erica , Castillo, Jorge J. , Costello, Caitlin , Devarakonda, Srinivas , Garfall, Alfred L. , Htut, Myo , Kang, Yubin , Lee, Hans C. , Martin, Thomas G. , Rosenberg, Aaron , Schroeder, Mark A. , Sherbenou, Daniel W , Suvannasankha, Attaya , Valent, Jason Neil , Kumar, Rashmi

Mayo Clinic

Journal of the National Comprehensive Cancer Network | December 11, 2023 | Volume: 21 | Issue: 12 | Pages: 1281-1301

10.6004/jnccn.2023.0061 | PMID 38081133 Get It

The treatment of relapsed/refractory multiple myeloma (MM) has evolved to include several new options. These include new combinations with second generation proteasome inhibitors (PI); second generation immunomodulators, monoclonal antibodies, CAR T cells, bispecific antibodies, selinexor, venetoclax, and many others. Most patients with MM undergo several cycles of remissions and relapse, and therefore need multiple lines of combination therapies. Selecting treatment options for relapsed/refractory MM requires consideration of resistance status to specific classes, and patient-specific factors such as age and other comorbidities should be considered. The NCCN Guidelines for MM provide a framework on which to base decisions regarding workup, treatment, and follow-up of newly diagnosed and previously treated MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to relapsed/refractory disease.
Mitigating Fracture of the Acromion and Scapular Spine After Reverse Shoulder Arthroplasty
Buchanan, Timothy R. , Bindi, Victoria E. , Caban-Klepac, Ettienne , Hones, Keegan M. , Wright, Thomas W. , King, Joseph J. , Hao, Kévin A. , Schoch, Bradley S , King, Joseph J , Hao, Kevin A , Hones, Keegan M , Schoch, Bradley S.

Mayo Clinic

JBJS Reviews | December 11, 2023 | Volume: 11 | Issue: 12 | Pages: No page available

10.2106/jbjs.rvw.23.00175 | PMID 38079495 Get It

» Biomechanical studies report that thin scapular spine (SS) morphology, superiorly placed glenoid components, and increased glenoid baseplate screws contribute to increased acromial and SS strain and may increase fracture risk. » Clinical risk factors of acromial and SS fractures after reverse shoulder arthroplasty include increasing age, female sex, osteoporosis, rheumatoid arthritis, thin midsubstance acromion morphology, previous acromioplasty, and surgical indication of cuff tear arthropathy. » Clinical studies show that, in isolation, excessive humeral lengthening, humeral lateralization, and glenoid medialization may increase risk of acromial and SS fractures. » Biomechanical studies suggest that a combination of glenoid medialization and humeral lateralization (MG/LH) may reduce fracture risk, although this requires clinical correlation. » Surgeons might reduce fracture risk in patients of high-risk groups by guarding against excessively lengthening the humerus, using a MG/LH prosthesis, and targeting screws to avoid the scapular notch and base of the SS. Level of Evidence: Level V . Narrative Review. See Instructions for Authors for a complete description of levels of evidence.
PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life
Decker, Jake E., Whitehead, Kevin J. , Conrad, Miles , Parambil, Joseph G. , Zumberg, Marc , Zhou, Jenny Y. , Boyer, Holly, Sutton, V. Reid , Bradley, Lauren, Clancy, Marianne S. , Wiśniewski, L, Carper, Benjamin , Catellier, Diane , Thomas, Sonia , Thomas, Sonia M , Carper, Benjamin , Al‐Samkari, Hanny , Kasthuri, Raj S. , Iyer, Vivek , Pishko, Allyson M. , Weiss, Clifford R. , Mazepa, Marshall , Wisniewski, Lisa, McCrae, Keith R.

Mayo Clinic

Blood | December 7, 2023 | Volume: 142 | Issue: Supplement 2 | Pages: LBA-3-LBA-3

10.1182/blood-2023-191983 Get It

Introduction Hereditary hemorrhagic telangiectasia (HHT), the second most common bleeding disorder worldwide, affects 1 in 5000 people and is characterized by extensive formation of telangiectasia and arteriovenous malformations (AVM) in mucosa, lung, brain, and liver. The primary clinical manifestation is recurrent, often severe epistaxis which commonly results in iron deficiency anemia, emergency room visits, hospitalizations, and reduced quality of life (QOL). Though non-randomized and/or underpowered studies have suggested that systemic bevacizumab or thalidomide may be effective in treating HHT, there have been no pivotal studies and therefore no FDA or EMA approved therapies. Methods PATH-HHT was an NHLBI-funded, randomized, placebo-controlled clinical trial conducted at 13 centers in the US to determine the safety and efficacy of pomalidomide for bleeding in HHT. Pomalidomide was supplied by Celgene and Bristol Myers Squibb. Patients were randomized in a 2:1 ratio to receive pomalidomide 4 mg daily or matching placebo for 6 months. Dose reductions were allowed for toxicity. The primary endpoint was the change in the Epistaxis Severity Score (ESS), a well-validated bleeding score in HHT, from baseline (randomization) to the end of the six-month treatment period, analyzed using a mixed model for repeated measures with adjustment for baseline value, center, treatment, visit, and treatment by visit interaction. Key secondary endpoints included 1) change in the average daily self-reported epistaxis duration from the four weeks preceding the baseline visit to weeks 20-24 of treatment, 2) amount of parenteral iron infused or blood transfused, and 3) change in QOL measurements, including an HHT-specific QOL score. Results PATH-HHT opened in November 2019 and was closed to enrollment by the NHLBI in June 2023 after a planned 75% interim analysis met a prespecified threshold for efficacy. A total of 144 patients were randomized and treated (95 pomalidomide, 49 placebo). Early study discontinuation was 25% in pomalidomide: 14% AE, 11% withdrawn, 1 unrelated death, compared with placebo (4% withdrawn). Across groups, 8% were terminated after 12 weeks for early study closure. Participants included 48% females, 11% non-white race; mean (± SD) age was 58.8±12.2 years. The mean ESS at baseline was 5.0±1.5 (4.9 pomalidomide, 5.2 placebo), consistent with moderate to severe epistaxis. At 24 weeks, the ESS in patients treated with pomalidomide decreased by a mean [95% CI] of -1.84 [-2.24, -1.44] and in the placebo group decreased by -0.89 [-1.39, -0.39] (mean difference -0.95 [-1.58, -0.32], p = 0.003) (Figure, Panel A). Difference between groups was apparent by 12 weeks (mean difference -0.52, 95% CI [-1.04, -0.01], p = 0.045). The HHT-specific QOL score, which ranges from 0 to 16 with higher scores indicating more limitations, also decreased more in the pomalidomide (mean -2.6, 95% CI [-3.3, -1.9]) vs the placebo group at 24 weeks (mean -1.2, 95% CI [-2.1, -0.3], p = 0.015) (Figure, Panel B). Adverse events that occurred more in the pomalidomide group included mild to moderate neutropenia (45% vs. 10%), constipation/diarrhea (60% vs. 37%), and rash (36% vs. 10%). Venous thrombosis occurred in 2% of patients in each group. Conclusion PATH-HHT is the largest and the first adequately powered, randomized trial of systemic therapy in HHT. The study demonstrated a significant and highly clinically relevant reduction in epistaxis in pomalidomide-treated patients as well as an improvement in the HHT-specific QOL score. Pomalidomide may offer a novel approach to management of HHT. Since plasma was collected from patients in this study before and at the end of treatment, additional studies may identify biomarkers predicting pomalidomide responses.